FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Automated Insulin Dosing Device System, Single Hormonal Control
PMA: P160017
·
Supplement: S093
·
Decision Apr 27, 2023
Classifications
1
FEI Numbers
16
Registration Numbers
16
Basic Information
- Device Name
- Automated Insulin Dosing Device System, Single Hormonal Control
- Trade Name
- MiniMed 770G System
- PMA Number
- P160017
- Supplement Number
- S093
- Device Class
- FDA Class 3
- Product Code
- OZP
- Generic Name
- Automated insulin dosing device system, single hormonal control
- Medical Specialty
- Unknown
- Advisory Committee
- Clinical Chemistry
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- April 27, 2023
- Date Received
- August 6, 2021
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for enabling the firmware over the air (FOTA) update for the MiniMed 770G system and the associated labeling changes.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OZP | Automated Insulin Dosing Device System, Single Hormonal Control | FDA class 3 | Unknown |